Balanced news tone
News Sentiment
LQDA sentiment intelligence
Liquidia Technologies Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-1.3% over one week, +9.4% over four weeks, trend active, and materially above fair value.
Liquidia Insider Sold Shares Worth $2,520,683, According to a Recent SEC Filing
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Liquidia Insider Sold Shares Worth $2,520,683, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 08:07
- Source
- MT Newswires
Liquidia Insider Sold Shares Worth $1,460,965, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 08:06
- Source
- MT Newswires
Liquidia Insider Sold Shares Worth $1,053,926, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 08:06
- Source
- MT Newswires
Does Liquidia (LQDA) Insider Selling Undercut Optimism Around YUTREPIA And Its Litigation Outlook?
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 15 Jul 2026 02:12
- Source
- Market source
Liquidia Corp’s CHRO Sarah Krepp sells $562,360 in shares By Investing.com
Liquidia Corp's CHRO, Sarah Krepp, sold 7,864 shares totaling $562,360 through a Rule 10b5-1 plan to cover taxes on vested restricted and performance stock units. This sale follows a significant 427% surge in Liquidia's stock over the past year. Despite the sale, Krepp still dire
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 02:17
- Source
- Investing.com Nigeria
Liquidia (LQDA) Expands YUTREPIA As Patent Case Turns More Favorable
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jul 2026 01:13
- Source
- Market source
Liquidia Corp (NASDAQ: LQDA) GC sells 14,738 shares after PSU vesting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp (LQDA) CHRO sells 7,864 shares in tax-related trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp (LQDA) CAO exercises PSUs, sells 9,002 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp (LQDA) CEO sells 35,249 shares and exercises PSUs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp (LQDA) CCO sells 9,539 shares to cover RSU taxes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp (LQDA) CFO sells shares under 10b5-1 tax plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp (LQDA) CMO sells 9,926 shares after PSU conversions
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, exercised performance stock units and subsequently sold 9,926 common shares of LQDA. The sales, executed on July 13, 2026, under a Rule 10b5-1 plan, were primarily to cover tax obligations arising from the settlement of previo
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia CAO Dana Boyle sells 9,002 shares for $643,739
Liquidia's Chief Accounting Officer, Dana Boyle, sold 9,002 shares of LQDA stock for approximately $643,739 on July 13, 2026. These sales, executed under a Rule 10b5-1 plan, primarily covered taxes related to vesting restricted stock units. Despite Boyle's sales, Liquidia's stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Investing.com
Liquidia Corp (LQDA) officer sells 1,185 shares in 10b5-1 tax sale
Liquidia Corp's Chief Development Officer, Sanjeev Khindri, sold 1,185 shares of the company's common stock on July 13, 2026, in two open-market transactions at prices of $71.52 and $71.39 per share. These sales, totaling approximately $85,000, were conducted under a Rule 10b5-1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Liquidia Corp CDO Khindri sells $84,740 in stock
Sanjeev Khindri, Chief Development Officer at Liquidia Corp (NASDAQ:LQDA), sold 1,185 shares totaling $84,740 on July 13, 2026. These sales were pre-arranged under a Rule 10b5-1 trading plan to cover tax obligations from vested restricted stock units. Despite the sale, which foll
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Investing.com
Liquidia Corp (LQDA) CBO sells 7,863 shares after award vesting
Liquidia Corp's Chief Business Officer, Jason Adair, sold 7,863 common shares for approximately $71.40–$71.52 per share on July 13, 2026. This sale was conducted under a Rule 10b5-1 plan to cover taxes associated with the vesting of restricted and performance stock units that wer
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 15 Jul 2026 00:17
- Source
- Stock Titan
Here’s Laughing Water Capital’s Updates on Liquidia Corp. (LQDA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 15:00
- Source
- Market source
Liquidia stock trades steadily as pulmonary hypertension focus stays on long-term opportunity
Liquidia Corp. stock (LQDA) is trading steadily, reflecting investor focus on regulatory milestones and commercialization prospects for its pulmonary arterial hypertension treatments rather than current earnings. The company specializes in targeted lung therapies, utilizing advan
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Jul 2026 17:11
- Source
- Ad-hoc-news.de
Liquidia Board Member Trades $6.05M In Company Stock
Liquidia board member Stephen M. Bloch sold 75,000 shares of company stock for $6.05 million, as disclosed in a recent SEC filing. The company (NASDAQ: LQDA) shows strong revenue growth of 4158.49% as of March 31, 2026, and a high gross margin, though its EPS lags the industry av
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 09 Jul 2026 15:11
- Source
- Benzinga
Liquidia(LQDA.US) Director Sells US$6.05 Million in Common Stock
A director at Liquidia (LQDA.US) recently sold common stock valued at $6.05 million. This transaction indicates a significant insider sale, which some investors might view as a signal regarding the company's future prospects.
- Tone
- Negative 28/100
- Event
- Market update
- Published
- 08 Jul 2026 22:09
- Source
- Moomoo
Liquidia Corp director Stephen Bloch reports $6.05 million stock sales
Liquidia Corp director Stephen Bloch reported indirect stock sales totaling $6.05 million from July 6-7, 2026, with shares sold between $80.175 and $81.3128. Despite the sale, which occurred near the stock's 52-week high, InvestingPro data suggests the stock is undervalued. Bloch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 21:09
- Source
- Investing.com
[Form 4] Liquidia Corp Insider Trading Activity
A Form 4 filing reveals that Canaan VIII L.P., an entity associated with Liquidia Corp director Stephen M. Bloch, sold 75,000 shares of Liquidia Common Stock in open-market transactions. These sales occurred at weighted average prices in the low-$80 range, totaling over $6 millio
- Tone
- Negative 26/100
- Event
- Market update
- Published
- 08 Jul 2026 20:09
- Source
- Stock Titan
Can Liquidia (LQDA) Justify Its Valuation After Yutrepia Uptake And Profitable Quarters?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 15:46
- Source
- simplywall.st
BlackRock (LQDA) discloses 10.55M shares, 11.9% stake in LIQUIDIA
BlackRock, Inc. has disclosed a beneficial ownership of 10,551,901 shares, representing an 11.9% stake in LIQUIDIA CORP (LQDA) as of June 30, 2026. The SEC filing, a Schedule 13G/A amendment, indicates that BlackRock holds sole voting power over 10,434,552 shares and sole disposi
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 15:41
- Source
- Stock Titan
LQDA Stock Soars 129.7% YTD: Is There More Room for Growth?
Liquidia Corporation (LQDA) stock has surged 129.7% year-to-date, driven by strong quarterly results and the successful uptake of its lead drug, Yutrepia, which treats pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Yutrepia h
- Tone
- Positive 81/100
- Event
- Earnings
- Published
- 07 Jul 2026 16:41
- Source
- TradingView
Director At Liquidia Sells $1.99M Of Stock
A director at Liquidia (NASDAQ: LQDA), Stephen M Bloch, sold 25,000 shares of the company's stock worth $1,986,694, according to a recent SEC filing. The company shows strong revenue growth of 4158.49% and a high gross margin of 91.08%, but its EPS is below industry norms and its
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 15:12
- Source
- Benzinga
Liquidia Insider Sold Shares Worth $1,986,695, According to a Recent SEC Filing
An insider at Liquidia recently sold shares valued at $1,986,695. This transaction was disclosed in a recent SEC filing, indicating a significant sale by a company insider.
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 06 Jul 2026 22:10
- Source
- Moomoo
Fund tied to Liquidia (LQDA) director sells 25K common shares
A fund associated with Liquidia Corp (LQDA) director Stephen M. Bloch, Canaan VIII L.P., sold a total of 25,000 common shares in open-market transactions for approximately $79-$80 per share. Despite these sales, the fund retains a substantial indirect holding of 855,926 shares, a
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 06 Jul 2026 22:10
- Source
- Stock Titan
Price to earnings forward of Liquidia Corporation – NASDAQ:LQDA
This article provides a financial snapshot for Liquidia Corporation (NASDAQ: LQDA), focusing on its forward price-to-earnings ratio. It indicates that the company is listed on the Nasdaq Stock Market under the Health Technology/Pharmaceuticals sector. The content appears to be a
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 05:10
- Source
- TradingView